APA

Meijer E., Gansevoort R. T., de Jong P. E., van der Wal A. M., Leonhard W. N., de Krey S. R., van den Born J., Mulder G. M., van Goor H., Struck J., de Heer E. & Peters D. J. M. (20111220). Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Chicago

Meijer E, Gansevoort R T, de Jong P E, van der Wal A M, Leonhard W N, de Krey S R, van den Born J, Mulder G M, van Goor H, Struck J, de Heer E and Peters D J M. 20111220. Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Harvard

Meijer E., Gansevoort R. T., de Jong P. E., van der Wal A. M., Leonhard W. N., de Krey S. R., van den Born J., Mulder G. M., van Goor H., Struck J., de Heer E. and Peters D. J. M. (20111220). Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

MLA

Meijer E, Gansevoort R T, de Jong P E, van der Wal A M, Leonhard W N, de Krey S R, van den Born J, Mulder G M, van Goor H, Struck J, de Heer E and Peters D J M. Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 20111220.